Skip to main content
ChemPartner PharmaTech Co., Ltd. logo

ChemPartner PharmaTech Co., Ltd. — Investor Relations & Filings

Ticker · 300149 ISIN · CNE100000Y27 Shenzhen Stock Exchange Professional, scientific and technical activities
Open in API
Filings indexed 2,256 across all filing types
Latest filing 2019-03-29 Major Shareholding Noti…
Country CN China
Listing Shenzhen Stock Exchange 300149

About ChemPartner PharmaTech Co., Ltd.

https://www.chempartner.com

ChemPartner PharmaTech Co., Ltd. is a global research and development organization providing comprehensive drug discovery and development services. Operating as a Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO), the company supports pharmaceutical and biotechnology clients through an integrated service platform. Core capabilities include medicinal chemistry, biology, pharmacology, drug metabolism and pharmacokinetics (DMPK), and toxicology. The organization also offers specialized expertise in biologics discovery, protein engineering, and antibody development. ChemPartner facilitates the transition from early-stage research to clinical development through its pharmaceutical development and manufacturing capabilities, utilizing advanced technology to accelerate the discovery and production of novel therapeutic agents.

Recent filings

Filing Released Lang Actions
关于控股股东部分股份质押的公告
Major Shareholding Notification Classification · 95% confidence The document is a public announcement regarding the pledge of shares by a controlling shareholder. It details the number of shares pledged, the pledge start and end dates, the pledgee, and the proportion of shares pledged relative to total holdings and company stock. There is no financial report, earnings data, or management discussion. The document is a regulatory announcement about share pledging activity, which fits the category of Major Shareholding Notification (MRQ). The document length is short and focused on shareholding changes, not a full report or announcement of a report publication.
2019-03-29 Chinese
关于投资医药创新产业基金的进展公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the progress of an investment in a pharmaceutical innovation industry fund by the company Quantum Hi-Tech (China) Biological Co., Ltd. It details the signing of partnership agreements, fund structure, investment decisions, and recent investment activities. The content focuses on investment updates and fund management rather than financial results, regulatory certifications, or shareholder voting outcomes. It is not a full financial report, earnings release, or management discussion. The document is a formal announcement of investment progress and related corporate actions, fitting the category of Capital/Financing Update (CAP). The document length (6573 characters) supports it being a detailed announcement rather than a brief notice or a full report like an annual or interim report.
2019-03-28 Chinese
2019年第一次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled as a resolution announcement for the "2019 First Extraordinary General Meeting of Shareholders" of Quantum Hi-Tech (China) Biological Co., Ltd. It details the meeting date, voting methods, attendance, and voting results on specific proposals. It also includes a legal opinion from a law firm confirming the legality and validity of the meeting and voting process. There is no financial data, no detailed report or presentation, and the document is relatively short (1735 characters). The content is focused on announcing the results of a shareholder meeting and the resolutions passed. This fits the definition of a Declaration of Voting Results & Voting Rights Announcement (DVA).
2019-02-28 Chinese
2019年第一次临时股东大会的法律意见书
Regulatory Filings Classification · 95% confidence The document is a legal opinion letter from a law firm regarding the convening, attendance, and voting procedures of a 2019 first extraordinary general meeting (临时股东大会) of Quantum Hi-Tech (China) Biological Co., Ltd. It details the legality and compliance of the meeting process, attendance, and voting results. It is not the actual shareholder meeting materials or voting results announcement but a legal opinion on the meeting's procedural compliance. The document is about a shareholders' meeting but is not the meeting materials (AGM Information) nor the voting results announcement (DVA). It is a legal opinion letter related to the shareholders' meeting, which fits best under Regulatory Filings (RNS) as it does not fit other categories and is a compliance/legal document.
2019-02-28 Chinese
2018年度业绩快报
Earnings Release Classification · 95% confidence The document is titled '2018 年度业绩快报' which translates to '2018 Annual Performance Express Report' or '2018 Annual Earnings Quick Report'. It contains preliminary financial data for the full year 2018, including revenue, profit, net income, and other financial metrics. The text explicitly states that the data is preliminary, unaudited, and subject to change in the final annual report. It also mentions that the detailed financial data will be disclosed in the 2018 Annual Report. The document is relatively short (1871 characters) and serves as an initial earnings announcement rather than a full comprehensive report. This matches the definition of an Earnings Release (ER), which is an initial announcement of quarterly or periodical financial results with key highlights only. Therefore, the document should be classified as an Earnings Release (ER).
2019-02-26 Chinese
关于召开2019年第一次临时股东大会的提示性公告
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a detailed announcement about the convening of the 2019 first extraordinary general meeting (临时股东大会) of the company Quantum Hi-Tech (量子高科). It includes information about the meeting date, voting procedures (both onsite and online), registration details, agenda items, and attachments such as proxy forms and voting instructions. There is no financial data, earnings, or report content included. The document serves as a notice to shareholders about the meeting and how to participate and vote. It is not a report itself but an announcement related to a shareholder meeting. Therefore, it fits the category of a Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings.
2019-02-25 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.